Graphene is an innovative nanomaterial, made of two-dimensional honeycomb-like carbon lattice, with potential in many different applications. Studying the behaviour of graphene-related materials (GRMs) in biological systems is, therefore, crucial to assess possible side effects. In this work is studied the biotransformation and biological impact of few layer pristine graphene (FLG) and graphene oxide (GOX), following ingestion as exposure route. To mimic FLG and GOX ingestion, an in vitro digestion assay based on a standardized operating procedure (SOP) is applied. The assay simulates the human ingestion of GRMs during their dynamic passage through the different environments of gastro-intestinal (GI) tract (salivary, gastric, intestinal). Physical-chemical changes of GRMs during the digestion process are assessed through a detailed Raman spectroscopy characterization. Moreover, the effect of chronic exposure to digested GRMs on integrity and functionality of an in vitro model of intestinal barrier is also determined according to a second SOP.
Introduction
In the latest years, the interest in graphene have grown continuously [1] [2] . Graphene is a single layer of sp 2 -hybridized carbon atoms tightly packed in a two-dimensional honeycomb lattice [1] [2] (PNAS, Novoselov 2005) . The group of graphene-related materials (GRMs) comprises single-layer graphene, few-layer graphene (FLG), graphene oxide (GOX), reduced graphene oxide (rGOX), graphene nanosheets, graphene nanoribbons, and graphene quantum dots [2] [3] [4] . GRMs have distinctive characteristics e.g. that make them interesting candidates for technological and biomedical applications, ranging from (opto)electronic to electrochemical devices, energy storage, cell imaging, drug delivery, and biosensors 3, [5] [6] [7] [8] . Moreover, the use of graphene as nanofiller in food packaging has also been investigated because of its exceptional ability to limit oxygen permeation (some comparison with an state-of the-art material could aid to strength this idea) and light transmission in polymeric films (why is this important, also is necessary to put a number and/or comparison with a current used material) [9] [10] [11] .
The integration of GRMs into consumer products makes crucial to assess their potential risk for humans, by defining their toxicological profiles and biological fate within the exposed organisms 12 .
Exposure to GRMs can mainly occur via inhalation, ingestion, and/or skin contact. Amongst these, inhalation is considered as the most relevant way of entrance of GRMs in the human body and, hence, several in vitro and in vivo studies have recently focused their attention on this route of exposure 3, [13] [14] . After inhalation, however, GRMs may also enter the digestive apparatus, through swallowing [15] [16] [17] . In addition, unintentional direct ingestion of GRMs could occur from contaminated waters or upon their release from food packaging. Despite such important route of entrance, few works on the fate and toxicological effects of GRMs upon oral exposure have been reported to date [18] [19] [20] [21] . Moreover, in vitro models only partially mimic the real in vivo environment, e.g., GRMs directly suspended in cell culture media without previous contact with GI juices 18 or pre-incubated with acidic buffers that only account for the low pH of the gastric compartment 19 . Therefore, in vitro data are poorly comparable to complex in vivo conditions, including strong pH shifts and variable concentrations of salts and enzymes during ingestion. Hence, a more reliable approach considering all steps occurring after oral ingestion is required for a realistic assessment of biotransformation of GRMs in the GI tract. In fact, as for other nanomaterials [22] [23] [24] [25] , the unique physical-chemical characteristics of GRMs may change depending on the surrounding conditions, such as temperature, pH, concentration, salts, etc, that, in turn, may modify the toxicological profile of GRMs on biological systems. Moreover, recent findings have shown that carbon nanomaterials, including GOX and oxidized carbon nanotubes (CNTs), may be degraded by oxidase enzymes, such as horseradish peroxidase (HRP) and human myeloperoxidase (hMPO) both in vitro and in vivo [26] [27] [28] . Notably, as also proposed in some recent categorization schemes for nanomaterials [29] [30] , a major concern for the potential harmfulness of GRMs is related to their biological transformation/persistence or release of toxic compounds through degradation.
Different digestion models have been applied to test changes in nanoparticle behaviour, mainly focusing on aggregation/agglomeration and cytotoxicity 31 24, 32 33 . In this work, we used a dynamic in vitro digestion assay, developed to mimic the human ingestion of nanoparticles and monitor their biotrasformations during the passage through the GI tract simulated environments (salivary, gastric, intestinal) 24 . The assay is part of a SOP 34 developed in the EU project NANoREG (A common European approach to the regulatory testing of nanomaterials. http://www.nanoreg.eu/). The application of SOPs has the scope to foster data reproducibility by lowering result variability, which often affects the benchmarking analysis among nanomaterials 35 . The assay had been validated using a range of reference nanoparticles (from JRC European repository list) for which a detailed physicalchemical characterization in pristine conditions is available (https://ec.europa.eu/jrc/en/scientifictool/jrc-nanomaterials-repository). Here, we investigated biotransformation, biodurability in GI fluids, cell uptake, cytotoxicity, and inflammatory response of FLG and GOX upon the in vitro digestion. In particular, the first objective of this study is the understanding of the impact of each step of the in vitro digestion process on the physical-chemical properties of FLG and GOX flakes by cell%20barrier%20model%2029052015%20V9.pdf).
Materials and Methods

GRM synthesis and characterization
Few layer pristine graphene (FLG) is prepared by ball-milling as described elsewhere 37 .
Monolayer/few layer graphene oxide (GOX) is provided by Grupo Antolin Ingenieriá (Burgos, Spain).
GRM morphology and lateral size are analyzed by Jeol JEM 1011 transmission electron microscope (TEM) (Jeol, Japan). Thermogravimetric analysis (TGA) is carried out using a TGA Q50 (TA Instruments) at 10 °C min -1 under nitrogen flow, from 100 °C to 800 °C. Measurements of zeta potential of FLG and GOX are carried out with a Zetasizer Nano-ZS (Malvern Instruments, Worcestershire, UK) at 25 °C in low ionic strength buffers at different pH. All measurements ae performed in triplicate for each sample.
In vitro digestion assay
The digestion of GRMs is carried out by an in vitro digestion assay that simulates the human ingestion of nanomaterials. The assay is based on a dynamic model developed by Bove et al. 24 that is also available as a SOP 34 from the European project Nanoreg (NANoREG -A common European approach to the regulatory testing of nanomaterials. http://www.nanoreg.eu/). Briefly, the assay employs artificial juices simulating the human digestive compartments (mouth, stomach and small intestine), which are dynamically added into the Eppendorf tube under stirring conditions. The assay is slightly modified. The digestive juices are prepared in sterile conditions by combining salt solutions, organic compounds and proteins to obtain the final concentrations in a total reaction volume of 10 ml as reported in Table S1 . The final pH of each single juice is 6.8 ± 0.1 for saliva, 1.3 ± 0.1 for stomach, 8.1 ± 0.1 for duodenal and 8.2 ± 0.1 for bile. The juices are pre-heated to 37 °C for at least two hours before starting the experiments. All chemicals were purchased by Sigma Aldrich.
The assay is conducted following the reported procedure: 20 µl of the FLG and GOX dispersions (0.09 and 0.45 mg ml -1 , respectively) are added into a 1.5 mL Eppendorf tube. Afterward, the digestive juices are added in a temporal sequence that simulated the transit of food bolus along the gastrointestinal apparatus 38 . To reproduce the mouth compartment, 60 µl of salivary juice at pH 6.8
are mixed with 20 µl of the GRM dispersion and shacked at 37 °C for 5 minutes. After incubation, 1
µl of the mouth sample was collected and dried on a silicon wafer for Raman spectroscopy analysis 
Trans-Epithelial Electrical Resistance (TEER) measurements
Before and after 1, 5 and 9 days of incubation with digested GRMs, integrity of differentiated Caco- Inserts are considered suitable for experiments if TEER value is >150 Ω x cm 2 .
Lucifer yellow (LY) assay
At the end of experiments, the impact of digested GRMs on epithelium integrity is evaluated by lucifer yellow (LY, Sigma) assay to determine any difference in this paracellular marker ability to cross the monolayer between GRM-treated inserts and untreated inserts. 
Transmission electron microscopy (TEM)
To observe the formation of microvilli and tight junctions as well as the intracellular localization of digested GRMs, the Caco-2 barriers are fixed for 2 h in 1.5% glutaraldehyde in 0.1 M Sodium
Cacodylate buffer (pH 7.4), post fixed in 1% osmium tetroxide in the same buffer and stained overnight with 1% uranyl acetate aqueous solution. The barriers are then dehydrated in a graded ethanol series, infiltrated with propylene oxide and embedded in epoxy resin (Epon 812, TAAB).
Semi-thin and thin sections of the embedded cell monolayer are cut with an ultramicrotome (UC6, Leica) equipped with a diamond knife (Diatome). Images are collected with a Jeol JEM 1011 (Jeol, Japan) electron microscope, operating at an acceleration voltage of 100 kV, and recorded with a 11
Mp fiber optical charge-coupled device (CCD) camera (Gatan Orius SC-1000).
Cell viability assay
Cell viability is evaluated by measuring the cell metabolic activity using CellTiter 96® AQueous One 
LDH assay
After cell interaction with digested GRMs as described above, to assess the impact on cell membrane, the lactate dehydrogenase (LDH) leakage assay is performed onto 96-well microplates by using the 
Results and Discussion
Biotransformation of GRMs during the digestion process
A schematic representation of the in vitro digestion assay adapted for GRM ingestion is reported in Figure 1 and Table S1 . This proposed model mimics the gastro-intestinal passage and simulates the oral, gastric, and small intestine conditions. To mimic the gastro intestinal process, synthetic digestive juices are used, and the pH changes, transit times, relevant enzymes, and protein compositions during the digestion process are taken into account, as described in previous reports 24, 38 . In this study, FLG and GOX flakes are used as model GRMs. instance, it has been reported that, during digestion, silver nanoparticles are fully dissolved to silver ions that, in turn, interact with the components of digestive juices, forming secondary silver-organic complexes 24 . Moreover, metal containing nanoparticles, once internalized by cells according to endocytosis pathways, can be degraded in the lysosomal compartment, due to the low pH and degradative environment [22] [23] 40 . It has also been recently reported that FLG and GOX can be degraded by peroxidases (hMPO and HRP) in vitro [26] [27] [28] .
Starting from these observations, Raman spectroscopy analysis is carried out on GRMs incubated at specific time intervals in the different digestive juices, to assess their biotransformation/biodegradation in conditions that mimic the digestion process. Raman spectroscopy has demonstrated to be a powerful tool for the characterization of nanomaterials, e.g., in terms of doping [41] [42] [43] , functionalization 44 , oxidation [45] [46] . In particular, for GRMs, Raman spectroscopy has been widely used to identify the number of layers, defects type and doping, disorders on the crystalline structure, chemical modifications, just to cite a few [47] [48] [49] [50] . In particular, the position and full width at half maximum (FWHM) of the G band (pos(G) and FWHM(G), respectively), change due to electronphonon coupling and the Kohn anomaly at the Γ point 42, 50 . The frequency of the G band has the lowest value when the Fermi level is at the Dirac point, and the pos(G) stiffens as the doping concentration increases 43 . Contrary, the FWHM(G) decreases as the doping concentration increases [51] [52] . While the G band obeys to the doping concentration, the 2D band is sensitive to the doping type, this means that pos(2D) increases if the doping is p-type and decreases for n-type doping 51 . The 2D band intensity, I(2D), is also affected by the doping concentration, but it is insensitive to the doping type, decreasing with the increase of doping 43, 45 . In the same way, as the 2D band is doping-sensitive, the first order D band is doping-sensitive as well 54 . The I(D)/I(G) reaches the minimum value when the Fermi level (which can be tuned according to the amount and type of dopants attached to the graphene) approaches the Dirac point. I(D)/I(G) reaches the maximum value when the Fermi energy is at half of the excitation energy 55 , i.e., the Pos(D) up-shifts with p-type doping and down shifts with n-type doping 55 . Moreover, also the FWHM increases with n-type doping and decreases for the ptype one 55 . Structural defects, aside from being the responsible for the D band activation 49, 56 , also Combined to the fact that the electronic and optical properties of graphene change due to defects and doping, the Raman spectra also change with the number of stacked graphene layers 47, 58-59 , i.e., the 2D band changes in lineshape and position for an increasing number of layers 47, 58 . These variations in the Raman spectra make the data interpretation challenging for a heterogeneous sample, as it is the case of the mechano-chemical exfoliated graphene or GOX flakes. As a consequence, an extensive statistical analysis is a compulsory step, in order to understand the physical/chemical changes of graphene/GOX dispersed in biological media.
The most significant results of the Raman statistical analysis on FLG and GOX are shown in 
Assessment of intestinal epithelium integrity upon chronic exposure to digested GRMs
The intestinal barrier is one of the most important biological barriers within the human body. It attends to several functions, such as nutrient uptake, protection against pathogens, and preservation concentrations ranging from 1 to 100 µg ml -1 were considered to be a realistic dose range in vitro 65, [67] [68] . Additionally, the used FLG and GOX concentrations are selected in order to have the maximum possible concentration, allowing good dispersion/stability of the nanomaterials (in particular, the concentration of pristine FLG is lower than GOX, due to its worse dispersibility in water, Z-potential of 28 mV at pH 7 for FLG and 40 mV for GOX see Figure S1 ).
The integrity of the intestinal layer upon chronic incubation with digested GRMs is assessed by measuring Trans-Epithelial Electrical Resistance (TEER) and passage to the Bl compartment of LY, a marker of paracellular transport (Figure 6d and e). Epithelial layers treated with digested GRMs do not show detectable differences in TEER and LY with respect to non-treated controls (Figure 6d and e). These results indicated that digested GRMs are well tolerated by the intestinal barrier and does not induce its disruption/perturbation upon chronic exposure. Similar results were also reported by Bohmert et al. after treatment of Caco-2 cell layers with digested silver nanoparticles 65 . In that case, no variations in impedance measurements were observed up to 24 h prolonged incubation.
Cellular uptake and intracellular localization of digested GRMs
Since digested GRMs do not compromise the integrity of the intestinal barrier, their capability to be internalized by Caco-2 cell layers was investigated by confocal microscopy after 9 days of chronic incubation. As shown in Figure 7a mechanisms to penetrate the cell membrane and, consequently, they preferentially accumulate into endo-lysosomes 23, 39, 69, 76 . Therefore, to elucidate the mechanisms of cellular uptake of digested FLG and GOX, the lysosomal localization of internalized GRMs within the intestinal barriers is analysed.
Immunofluorescence results indicate the co-localization of digested GRMs with the lysosomal marker LAMP1, thus suggesting that endocytosis contribute to the internalization of FLG and GOX flakes ( Figure S4 ).
Because of the degradative environment of the lysosomal compartment where digested FLG and GOX are localized after cellular uptake, additional studies to assess biocompatibility of GRMs on undifferentiated/proliferating Caco-2 cells were carried out. Although only differentiated Caco-2 cells represent the epithelial cell layer of the small intestines, immature intestinal cells are also present in the small intestines, due to cell renewal, and they are proved to be more sensitive to external disturbances, e.g., when exposed to silver nanoparticles after in vitro digestion 65 with previously reported data on the same cell type [18] [19] . Therefore, lack of cytotoxicity in these cells after exposure to digested GRMs may likely suggest no toxicity on intestinal barrier.
Inflammatory response of intestinal epithelium to digested GRMs
In vivo studies on laboratory animals provided some indications that inflammation may be involved in the toxicity of GRMs upon inhalation, and that the extent of inflammatory response could depend on the physical-chemical characteristics (i.e. lateral size, oxidation) of GRMs [13] [14] . Therefore, the release of inflammatory cytokines in the apical and basolateral media is measured to evaluate the possible triggering of inflammation by the intestinal layers upon chronic exposure to the digested GRMs. Caco-2 cell layers usually show a significant increase of IL-8 and MCP-1 levels when stimulated with inflammatory agents [77] [78] [79] . In our experiments, the levels of IL-8 and MCP-1 are comparable to untreated cell layers used as negative control (Figure 8 ). On the contrary, positive stimulation with LPS increase the release of the two cytokines ( Figure 8) . Hence, at variance with other nanomaterials 80 , digested GRMs do not induce any significant pro-inflammatory effect on the intestinal epithelium in vitro. A possible explanation for this effect could be related to the larger dimensions of GRMs after digestion, due to aggregation. In particular, GRM aggregates could have different transport rates and be retained outside the cell layer, unlike smaller nanomaterials or ions that may cross the intestinal layer and reach the cells more easily, inducing stronger inflammatory effects. This is consistent with previous findings using Ag nanoparticles, where only smaller 20 nm particles up-regulated the IL-8 expression in Caco-2 cell layers, while bigger 100 nm Ag nanoparticles did not [77] [78] . Thus, the immobilization of the large GRM aggregates, due to the sizeexclusion by the intestinal barrier, could result in a reduced cellular uptake and low cytokine release.
Conclusions
In this work, we investigated the biotransformation and biological impact of few layers graphene and graphene oxide flakes upon ingestion, by using the NANoREG standard methods simulating in vitro digestion. Our results highlighted the influence of digestive juices in modulating few layers graphene and graphene oxide physical-chemical properties. In particular, the interaction of both materials with ions and other molecular components present in digestive juices resulted in evident doping effects and no structural changes. This interaction influenced the aggregation state of few layers graphene and graphene oxidewith important consequences in bioaccessibility of these materials to the intestinal layer. In fact, digested GRMs were well tolerated by the intestinal barrier up to 9 days of exposure, not inducing detectable damage, even though large GRM aggregates were associated to its apical side. The immobilization of the GRM aggregates, due to the size-exclusion by the typical brush border of the intestinal barrier, resulted in: i) reduced cellular internalization, ii) no short-term cytotoxicity and iii) low cytokine release. However, because of the observed GRMs biodurability, regardless of the complex and harsh environments they experienced during the digestion simulation and their partial cellular uptake, additional investigations on their long-term fate are necessary in future studies to further assess their biocompatibility profile. 
